5 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $1M | -$3M | -37.0% | -711.3% | -$8M | $220000 | $585000 |
| 2024 | $643000 | -$10M | -43.7% | -1493.8% | -$7M | $5M | $172000 |
| 2023 | $1M | -$34M | -12.6% | -671.2% | -$5M | $930000 | $47000 |
| 2022 | $1M | -$30M | -31.2% | -669.1% | -$5M | — | $271000 |
| 2021 | — | $5M | — | — | — | — | $453151 |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $96000 | -$2M | -395.8% | -2658.3% | -$2M | $176000 | $233000 |
| Dec '25 | $891000 | -$3M | 18.5% | -345.9% | -$2M | $220000 | $585000 |
| Sep '25 | $177000 | -$741000 | -125.4% | -1262.7% | -$2M | — | $149000 |
| Jun '25 | $155000 | $3M | -155.5% | -1331.0% | -$2M | — | $122000 |
| Mar '25 | $137000 | -$2M | -163.5% | -1623.4% | -$2M | $5M | $144000 |
| Dec '24 | $26000 | -$2M | -100.0% | -10446.2% | -$2M | $5M | $172000 |
| Sep '24 | $142000 | -$2M | -59.2% | -1645.1% | -$2M | $5M | $2M |
| Jun '24 | $227000 | -$4M | -44.9% | -1081.1% | -$2M | $2M | $407000 |
| Mar '24 | $248000 | -$2M | -27.8% | -847.2% | -$2M | — | $174000 |
| Dec '23 | $340000 | -$2M | 0.6% | -549.4% | -$2M | $930000 | $47000 |
| Sep '23 | $326000 | -$14M | 10.1% | -591.1% | -$1M | — | $612000 |
| Jun '23 | $173000 | -$10M | -32.9% | -908.1% | — | — | $3438 |
| Mar '23 | $200000 | -$8M | -44.5% | -734.5% | — | — | $10108 |
| Dec '22 | $263768 | -$3M | -54.4% | -2908.2% | $91M | — | $271000 |
| Sep '22 | $375000 | -$9M | -26.4% | -784.5% | — | — | $234923 |
| Jun '22 | — | $949937 | — | — | — | — | $7480 |
| Mar '22 | — | $2M | — | — | — | — | $159133 |
| Dec '21 | — | -$464481 | — | — | — | — | $453151 |
| Sep '21 | — | $1M | — | — | — | — | $533706 |
| Jun '21 | — | $4M | — | — | — | — | $802110 |
How the market has priced ONMD against its own fundamentals since 2023-11 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 4 years, OneMedNet Corp's revenue has grown 5.6% per year. These are computed facts, not advice.
As of FY2025, OneMedNet Corp reported $220000 of total debt against $585000 of cash; operating income covered interest expense -144.3×.
In FY2025, gross margin was -37.0%, operating margin -711.3%, and net margin -206.1%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.